أعرض في EDS

Supplementary Methods and Legend from The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma

التفاصيل البيبلوغرافية
العنوان:	Supplementary Methods and Legend from The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma
المؤلفون:	Jann N. Sarkaria, Nathalie Y.R. Agar, William F. Elmquist, Stuart D. Shumway, Bennett Ma, Vincenzo Pucci, Jeanette E. Eckel-Passow, Paul A. Decker, Zhenkun Lou, Debra L. Evans, Mark A. Schroeder, Brett L. Carlson, Katrina K. Bakken, Dustin Mueller, Dennis O. Iyekegbe, Shiv K. Gupta, David Calligaris, Jenny L. Pokorny
بيانات النشر:	American Association for Cancer Research (AACR), 2023.
سنة النشر:	2023
الوصف:	Supplementary Methods and Legend
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd5b3cca6382f37122b6f4223c2f884 https://doi.org/10.1158/1078-0432.22454534
حقوق:	OPEN
رقم الأكسشن:	edsair.doi.dedup.....edd5b3cca6382f37122b6f4223c2f884
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.